Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults

Ophthalmology

Volumn 110, Issue 7, 2003, Pages 1315-1320

  Rogers, Adam H ^b   Duker, Jay S ^a   Nichols, Neil ^b   Baker, Brad J ^b  

^a NEW ENGLAND EYE CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ADULT; ANGIOID STREAK; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; INFLAMMATION; MALE; MYOPIA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA EXAMINATION; RETROSPECTIVE STUDY; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

EID: 0037479025     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(03)00466-4     Document Type: Article

References (16)

1. Roberts WG, Hasan T. Role of neovasculature permeability on the tumor retention of photodynamic agents. Cancer Res 1992;52:924-30.
2. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photo-inactivation of a murine tumor. Cancer Res 1976;36:2326-9.
3. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol 1992;55:145-57.
4. Moan J, Peng Q, Evensen JF, et al. Photosensitizing efficiencies, tumor- and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer. Photochem Photobiol 1987;46:713-21.
5. Rosenthal I. Phthalocyanines as photodynamic photosensitizers. Photochem Photobiol 1991;53:859-70.
6. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two-year results of 2 randomized clinical trials - TAP report 2. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Arch Ophthalmol 2001;119:198-207.
7. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial - VIP report no. 1. Verteporfin in Photodynamic Therapy (VIP) Study Group. Ophthalmology 2001;108:841-52.
8. Cleasby GW. Idiopathic focal subretinal neovascularization. Am J Ophthalmol 1976;81:590-6.
9. Ho AC, Yannuzzi LA, Pisicano K, DeRosa J. The natural history of idiopathic subfoveal choroidal neovascularization. Ophthalmology 1995;102:782-9.
10. Watzke RC, Packer AJ, Folk JC, et al. Punctate inner choroidopathy. Am J Ophthalmol 1984;98:572-84.
11. Brown J, Folk JC, Reddy CV, Kimura AE. Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ophthalmology 1996;103:1100-5.
12. Thomas MA, Dickinson JD, Melberg NS, et al. Visual results after surgical removal of subfoveal choroidal neovascular membranes. Ophthalmology 1994;101:1384-96.
13. Olsen TW, Capone AC Jr, Sternberg P, et al. Subfoveal choroidal neovascularization in punctate inner choroidopathy. Ophthalmology 1996;103:2061-9.
14. Adelberg DA, Del Priore LV, Kaplan HJ. Surgery for subfoveal membranes in myopia, angioid streaks, and other disorders. Retina 1995;15:198-205.
15. Sickenberg M, Schmidt-Erfuth U, Miller JW, et al. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol 2000;117:327-36.
16. Spaide RF, Martin ML, Slakter J, Yannuzzi LA, et al. Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin. Am J Ophthalmol 2002;62-68.